Drug Profile


Alternative Names: S-metoprolol extended release/clopidogrel immediate release - Emcure

Latest Information Update: 08 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Emcure Pharmaceuticals
  • Class Antihypertensives; Antiplatelets; Class II antiarrhythmics; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines; Pyridines; Small molecules; Thiophenes
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Cardiovascular disorders; Hypertension; Thrombosis

Most Recent Events

  • 24 May 2010 Phase-III clinical trials in Cardiovascular disorders (prevention) in India (PO)
  • 24 May 2010 Phase-III clinical trials in Hypertension in India (PO)
  • 24 May 2010 Phase-III clinical trials in Thrombosis (prevention) in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top